RNA delivery biomaterials for the treatment of genetic and rare diseases

Genetic and rare diseases (GARDs) affect more than 350 million patients worldwide and remain a significant challenge in the clinic. Hence, continuous efforts have been made to bridge the significant gap between the supply and demand of effective treatments for GARDs. Recent decades have witnessed th...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Biomaterials 2019-10, Vol.217, p.119291-119291, Article 119291
Hauptverfasser:	Zhao, Weiyu, Hou, Xucheng, Vick, Olivia G., Dong, Yizhou
Format:	Artikel
Sprache:	eng
Schlagworte:	Animals Biocompatible Materials - therapeutic use CRISPR Gene Editing Gene Transfer Techniques Genetic and rare diseases (GARDs) Genetic Diseases, Inborn - therapy Humans mRNA Rare Diseases - therapy RNA - genetics RNA delivery biomaterials RNA therapeutics RNAi
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!